TIDMNLOK TIDMAVST

RNS Number : 1552Z

NortonLifeLock Inc.

12 September 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

12 September 2022

RECOMMED MERGER

of

AVAST PLC

with

NORTONLIFELOCK INC.

MERGER UPDATE

On 9 September 2022, Avast plc ("Avast") and NortonLifeLock Inc. ("NortonLifeLock" or the "Company") announced that, in connection with the Merger announced on 10 August 2021, the Court had sanctioned the Scheme at the Court Hearing, the terms of which are set out in the scheme document published on 28 October 2021 (the "Scheme Document"). Save as otherwise defined, capitalised terms in this announcement have the same meanings as set out in the Scheme Document.

As stated in the announcement published by Avast this morning, the Scheme became Effective today, 12 September 2022, and the Merger therefore completed.

In connection with the completion of the Merger, with effect from the end of the Company's annual general meeting to be held on 13 September 2022, the Company will expand the size of its Board from 9 to 10 members and appoint Ondrej Vlček and Pavel Baudiš to the Board. In addition, Mr. Vlček was appointed President of the combined Company. As previously announced, Vincent Pilette will be the Chief Executive Officer of the combined Company.

Mr. Vlček, age 45, served as Avast's chief executive officer from July 2019 through the completion of the Merger. From November 2018 through June 2019, Mr. Vlček was the president of Avast's Consumer business unit. Prior to this, he served as the EVP and GM of the Consumer business unit from October 2016 through October 2018, and was the COO and CTO of the same company from April 2014 through September 2016. Since October 2018, he has also been a member of the Forbes Technology Council. Mr. Vlček holds a masters of sciences in mathematical modeling from Czech Technical University in Prague.

In connection with Mr. Vlček's service as the President of the combined Company, the Company anticipates entering into an agreement with Mr. Vlček whereby Mr. Vlček will receive an annual base salary of approximately $700,000. He will also be eligible to participate in the Company's Executive Annual Incentive Plan and is expected to have an annual bonus target of approximately 100% of his annual base salary. The Company expects to grant Mr. Vlček a long-term incentive equity award for fiscal year 2023 with an aggregate fair value of $7,000,000. The award is expected to be comprised of 60% performance-based restricted stock units ("PRUs") and 40% time-based restricted stock units ("RSUs"). The PRU portion of the award is expected to vest in full upon the completion and achievement of the applicable performance targets during the three-year performance period ending on 4 April 2025. The RSUs are expected to have a three-year vesting provision, with 33% of the shares vesting approximately one year from the grant date, 33% vesting approximately two years from the grant date and 34% vesting approximately three years from the grant date. In addition, the Company expects to grant Mr. Vlček an equity award under the Company's Value Creation Program ("VCP") with an aggregate fair value of approximately $7,000,000. The award is expected to be comprised of 100% performance-based restricted stock units ("VCP PRUs"). The VCP PRUs will vest based upon the Company's share price appreciation, as measured against certain price targets and subject to the achievement of certain relative TSR threshold targets, in each case, as measured on the last day of fiscal year 2026, or 3 April 2026. The RSUs, PRUs and VCP PRUs will be subject to the standard terms and conditions of the Company's RSU, PRU and VCP PRU award agreements.

In connection with Mr. Baudiš' service as a member of the Board, he will receive substantially similar compensation to that paid by the Company to its non-employee directors as disclosed in the Company's 2022 Proxy Statement, filed with the U.S. Securities and Exchange Commission on 3 August 2022.

Enquiries

 
 NortonLifeLock 
 Mary Lai, Head of Investor Relations             IR@NortonLifeLock.com 
 Spring Harris, Head of Global Corporate          Press@NortonLifeLock.com 
  Communications 
  and PR 
 Evercore (Financial adviser to NortonLifeLock 
  and Bidco) 
 Naveen Nataraj                                   +1 (0)212 857 3100 
 Edward Banks                                     +44 (0)20 7653 6000 
 Anil Rachwani 
 Swag Ganguly 
 Wladimir Wallaert 
 Sard Verbinnen (Communications adviser to 
  NortonLifeLock) 
 Charles Chichester                               +44 (0)20 7467 1050 
 John Christiansen                                +1 (0)415 618 8750 
 Jared Levy                                       +1 (0)212 687 8080 
 Avast 
 Kalli Bowyer                                     IR@avast.com 
 Anca Timpescu 
 UBS (Financial adviser and Corporate Broker      Tel: +44 207 567 
  to Avast)                                        8000 
 Christian Lesueur 
 Rahul Luthra 
 Jonathan Rowley 
 Aadhar Patel 
 Meera Sheth 
 J.P. Morgan Cazenove (Financial adviser          Tel: +44 207 742 
  and Corporate Broker to Avast)                   4000 
 Bill Hutchings 
 James Robinson 
 James Summer 
 Jonty Edwards 
 Finsbury Glover Hering (Communications           Avast-LON@fgh.com 
  adviser to Avast) 
 Dorothy Burwell                                  Tel: +44 7733 294 
                                                   930 
 Alastair Elwen                                   Tel: +44 7557 549 
                                                   325 
 

Kirkland & Ellis LLP and Macfarlanes LLP are retained as (respectively) US and UK legal advisers to NortonLifeLock. White & Case LLP is retained as legal adviser to Avast.

Important notices relating to financial advisors

Evercore Partners International LLP ("Evercore"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser to NortonLifeLock and Bidco and no one else in connection with the Merger and will not be responsible to anyone other than NortonLifeLock or Bidco for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with any matter referred to herein or otherwise. Apart from the responsibilities and liabilities, if any, which may be imposed on Evercore by FSMA, or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Evercore nor any of its affiliates accepts any responsibility or liability whatsoever for the contents of this announcement, and no representation, express or implied, is made by it, or purported to be made on its behalf, in relation to any matter referred to herein, including its accuracy, completeness or verification, or any other statement made or purported to be made by it, or on its behalf, in connection with NortonLifeLock, Bidco or the matters described in this announcement. To the fullest extent permitted by applicable law, Evercore and its affiliates accordingly disclaim all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which it or they might otherwise have in respect of this announcement or any statement contained herein.

UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in Switzerland. It is authorised by the PRA and subject to regulation by the FCA and limited regulation by the PRA in the United Kingdom. UBS provided financial and corporate broking advice to Avast and no one else in connection with the process or contents of this announcement. In connection with such matters, UBS will not regard any other person as its client, nor will it be responsible to any other person for providing the protections afforded to its clients or for providing advice in relation to the process, contents of this announcement or any other matter referred to herein.

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove, ("J.P. Morgan Cazenove") and which is authorised in the United Kingdom by the PRA and regulated in the United Kingdom by the PRA and the FCA, is acting exclusively as financial adviser to Avast and no one else in connection with the Merger and will not regard any other person as its client in relation to the Merger and shall not be responsible to anyone other than Avast for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in connection with the Merger or any matter or arrangement referred to herein.

No offer or solicitation

This announcement is for information purposes only and is not intended to and does not constitute, or form any part of, an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Merger or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law or regulation. In particular, this announcement is not an offer of securities for sale in the United States. No offer of securities shall be made in the United States absent registration under the U.S. Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. Any securities issued as part of the Merger are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the U.S. Securities Act.

The Merger will be implemented solely in accordance with the Scheme Document (or, in the event that the Merger is to be implemented by means of a Takeover Offer, the offer document), which contains the full terms and conditions of the Merger, including details of how to vote in respect of the Scheme. Any voting decision or response in relation to the Merger should be made solely on the basis of the information contained in the Scheme Document, the Forms of Proxy, the Form of Election and the NortonLifeLock Prospectus . This announcement does not constitute a prospectus or a prospectus exempted document.

Overseas shareholders

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom (including Restricted Jurisdictions) should inform themselves about, and observe, any applicable legal or regulatory requirements. In particular, the ability of persons who are not resident in the United Kingdom or who are subject to the laws of another jurisdiction to vote their Avast Shares in respect of the Scheme at the Meetings, or to execute and deliver the Forms of Proxy (appointing another to vote at the Meetings on their behalf) or the Form of Election, may be affected by the laws of the relevant jurisdictions in which they are located or to which they are subject. Any failure to comply with applicable legal or regulatory requirements of any jurisdiction may constitute a violation of securities laws in that jurisdiction.

Copies of this announcement and any formal documentation relating to the Merger are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction, including any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of acceptance of the Merger.

If the Merger is implemented by way of a Takeover Offer (unless otherwise permitted by applicable law and regulation), the Takeover Offer may not be made, directly or indirectly, in or into or by use of the mails or any other means or instrumentality (including facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or any facility of a national, state or other securities exchange of, any Restricted Jurisdiction and the Merger will not be capable of acceptance by any such use, means, instrumentality or facilities or from within any Restricted Jurisdiction.

Further details in relation to Avast Shareholders in overseas jurisdictions are contained in the Scheme Document.

Notice to U.S. investors in Avast

The Merger relates to the shares of an English company and is being made by means of a scheme of arrangement under Part 26 of the Companies Act. A scheme of arrangement is not subject to the tender offer rules or the proxy solicitation rules under the U.S. Exchange Act and other requirements of U.S. law. Accordingly, the Merger is subject to the disclosure requirements and practices applicable to a scheme of arrangement involving a target company in England listed on the London Stock Exchange, which differ from the disclosure requirements of U.S. tender offer and proxy solicitation rules. If, in the future, Bidco exercises its right to implement the Merger by way of a Takeover Offer and determines to extend the Takeover Offer into the U.S., the Merger will be made in compliance with applicable U.S. laws and regulations.

The New NortonLifeLock Shares to be issued pursuant to the Merger have not been registered under the U.S. Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act. The New NortonLifeLock Shares to be issued pursuant to the Merger will be issued pursuant to the exemption from registration provided by Section 3(a)(10) under the U.S. Securities Act.

New NortonLifeLock Shares issued to persons other than "affiliates" of NortonLifeLock (defined as certain control persons, within the meaning of Rule 144 under the U.S. Securities Act) will be freely transferable under US law after the Merger. Persons (whether or not US persons) who are or will be "affiliates" of NortonLifeLock within 90 days prior to, or of the Combined Company after, the Effective Date will be subject to certain transfer restrictions relating to the New NortonLifeLock Shares under US law.

Neither the SEC nor any U.S. state securities commission has approved or disapproved of the New NortonLifeLock Shares to be issued in connection with the Merger, or determined if this announcement is accurate or complete. Any representation to the contrary is a criminal offence in the United States.

Financial information relating to Avast included in the Scheme Document has been prepared in accordance with accounting standards applicable in the United Kingdom and may not be comparable to financial information of U.S. companies or companies whose financial statements are prepared in accordance with U.S. GAAP. U.S. GAAP differs in certain significant respects from accounting standards applicable in the United Kingdom.

Avast is incorporated under the laws of England and Wales. In addition, some of its officers and directors reside outside the United States, and some or all of its assets are or may be located in jurisdictions outside the United States. Therefore, investors may have difficulty effecting service of process within the United States upon those persons or recovering against Avast or its officers or directors on judgments of United States federal, state or district courts, including judgments based upon the civil liability provisions of the U.S. federal securities laws. It may not be possible to sue Avast or its officers or directors in a non-U.S. court for violations of the U.S. securities laws.

Forward-looking statements

This announcement contains certain forward-looking statements with respect to the NortonLifeLock Group and the Avast Group. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "aim", "will", "may", "would", "could" or "should" or other words of similar meaning or the negative thereof. There are many factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Additional information concerning risk factors is contained in the Risk Factors sections of NortonLifeLock's most recent reports on Form 10-K and Form 10-Q, the NortonLifeLock Proxy Statement and the NortonLifeLock Prospectus, the contents of which are not incorporated by reference into, nor do they form part of, this announcement.

Forward-looking statements are based on numerous assumptions regarding the present and future business strategies of such persons and the environment in which each will operate in the future. By their nature, these forward-looking statements involve known and unknown risks, as well as uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this announcement may cause the actual results, performance or achievements of any such person, or industry results and developments, to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements. No assurance can be given that such expectations will prove to have been correct and persons reading this announcement are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. All subsequent oral or written forward-looking statements attributable to the NortonLifeLock Group or the Avast Group or any persons acting on their behalf are expressly qualified in their entirety by the cautionary statement above. None of NortonLifeLock, Bidco or Avast undertake any obligation to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law, regulation or stock exchange rules.

No profit forecasts or estimates

No statement in this announcement is intended as, or is to be construed as, a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per ordinary share, for NortonLifeLock or Avast, respectively for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per ordinary share for NortonLifeLock or Avast, respectively.

Publication on website

A copy of this announcement will be made available (subject to certain restrictions relating to persons resident in Restricted Jurisdictions) on Avast's website (at https://investors.avast.com/ ) and on NortonLifeLock's website (at https://investor.nortonlifelock.com/ ) by no later than 12 noon London time on the business day following the date of this announcement. Neither the contents of these websites nor the content of any other website accessible from hyperlinks on such websites is incorporated into, or forms part of, this announcement .

Important Information

If you are in any doubt about the contents of this announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor, accountant or independent financial advisor duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are a resident in the United Kingdom or, if not, from another appropriately authorised independent financial advisor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

OUPBKBBQQBKDKCD

(END) Dow Jones Newswires

September 12, 2022 10:43 ET (14:43 GMT)

Avast (LSE:AVST)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Avast Charts.
Avast (LSE:AVST)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Avast Charts.